Bench to bedside: The technology adoption pathway in healthcare

Clark, Daniel; Dean, Gerard; Bolton, Sarah; Beeson, Beth

doi:10.1007/s12553-019-00370-z

Cited by 21 publications

(17 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The readiness assessment should engage all parties, and broad participation is essential to success. 40,41 Table 3 provides guidelines for assessing practice setting readiness. A justification for implementing the chosen technology is needed to obtain leadership acceptance and funding support.…”

Section: The Role Of the Diabetes Care And Education Specialistmentioning

confidence: 99%

See 1 more Smart Citation

Technology Integration: The Role of the Diabetes Care and Education Specialist in Practice

Isaacs

Cox²,

Schwab

et al. 2020

Diabetes Educ

View full text Add to dashboard Cite

Purpose Technology is rapidly evolving and has become an integral component of diabetes care. People with diabetes and clinicians are harnessing a variety of technologies, including connected blood glucose meters, continuous glucose monitors, insulin pumps, automated insulin delivery systems, data-sharing platforms, telehealth, remote monitoring, and smartphone mobile applications to improve clinical outcomes and quality of life. Although diabetes technology use is associated with improved outcomes, this is enhanced when the person using it is knowledgeable and actively engaged; simply wearing the device or downloading an app may not automatically translate into health benefits. The diabetes care and education specialist (DCES) has a central role in defining and establishing a technology-enabled practice setting that is efficient and sustainable. The purpose of this article is to describe the role of the DCES in technology implementation and to demonstrate the value of diabetes technology in both the care of the individual and as a tool to support population-level health improvements. Conclusion By following the recommendations in this article, DCESs can serve as technology champions in their respective practices and work to reduce therapeutic inertia while improving health outcomes and providing patient-centered care for the populations they serve.

show abstract

Section: The Role Of the Diabetes Care And Education Specialistmentioning

confidence: 99%

“…Resource readiness 40,41 • Does the practice have the information technology (IT)/security infrastructure to support new technology?…”

Section: Readinessmentioning

confidence: 99%

Technology Integration: The Role of the Diabetes Care and Education Specialist in Practice

Isaacs

Cox²,

Schwab

et al. 2020

Diabetes Educ

View full text Add to dashboard Cite

show abstract

“…This disparity is generally attributed to the market barriers present in the sector that are impeding the adoption of innovations and therefore their spread. Innovations in healthcare do not follow a linear pathway even though there is still an inclination to see these as such [3]. Indeed, the innovation process in healthcare has been described as long, incremental and path-dependent [4], reflecting [5] recognition of the co-evolutionary and path-dependent nature of innovation processes more generally.…”

Section: Introductionmentioning

confidence: 99%

The Barriers of the Assistive Robotics Market—What Inhibits Health Innovation?

Noury

Walmsley

Jones

et al. 2021

Sensors

View full text Add to dashboard Cite

Demographic changes are putting the healthcare industry under pressure. However, while other industries have been able to automate their operation through robotic and autonomous systems, the healthcare sector is still reluctant to change. What makes robotic innovation in healthcare so difficult? Despite offering more efficient, and consumer-friendly care, the assistive robotics market has lacked penetration. To answer this question, we have broken down the development process, taking a market transformation perspective. By interviewing assistive robotics companies at different business stages from France and the UK, this paper identifies new insight into the main barriers of the assistive robotics market that are inhibiting the sector. Their impact is analysed during the different stages of the development, exploring how these barriers affect the planning, conceptualisation and adoption of these solutions. This research presents a foundation for understanding innovation barriers that high-tech ventures face in the healthcare industry, and the need for public policy measures to support these technology-based firms.

show abstract

“…The transition of a product from benchside to clinical use involves several stages and engagements with different stakeholders (1). The first interaction is often with regulators who provide marketing authorization following satisfactory review of the product's risk-benefit profile (i.e., evaluation of safety, efficacy, and quality).…”

Section: Introductionmentioning

confidence: 99%

Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges

2020

View full text Add to dashboard Cite

The need to optimize drug development and facilitate faster access for patients has ignited discussions around the importance of improving interactions between health technology assessment (HTA) bodies and regulatory agencies. In this study, we conducted a systematic review to examine processes, progress, outcomes, and challenges of harmonization/interaction initiatives between HTA bodies and regulatory agencies. MEDLINE, EMBASE, and the International Pharmaceutical Abstracts database were searched up to 21 October 2019. Searches for gray literature (working papers, commissioned reports, policy documents, etc.) were performed via Google scholar and several institutional websites. An online cross-sectional survey was also conducted among HTA (n = 22) and regulatory agencies (n = 6) across Europe to supplement the systematic review. Overall, we found that while there are areas of divergence, there has been progress over time in narrowing the gap in evidentiary requirements for HTA bodies and regulatory agencies. Most regulatory agencies (4/6; 67%) and half (11/22, 50%) of the HTA bodies reported having a formal link for "collaborating" with the other. Several mechanisms such as early tripartite dialogues, parallel submissions (reviews), adaptive licensing pathways, and postauthorization data generation have been explored as avenues for improving collaboration. A number of pilot initiatives have shown positive effects of these models to reduce the time between regulatory and HTA decisions, which may translate into faster access for patients to life-saving therapies. Thus, future approaches aimed at improving harmonization/interaction between HTA bodies and regulatory agencies should build on these existing models/mechanisms while Ofori-Asenso et al. Improving HTA-Regulatory Interactions examining their long-term impacts. Several barriers including legal, organizational, and resource-related factors were also identified, and these need to be addressed to achieve greater alignment in the current regulatory and reimbursement landscape.

show abstract

Bench to bedside: The technology adoption pathway in healthcare

Cited by 21 publications

References 8 publications

Technology Integration: The Role of the Diabetes Care and Education Specialist in Practice

Technology Integration: The Role of the Diabetes Care and Education Specialist in Practice

The Barriers of the Assistive Robotics Market—What Inhibits Health Innovation?

Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges

Contact Info

Product

Resources

About